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John PR Moore1,2* and John F Fraser2See related research by Lima and Bakker, http://ccforum.com/content/18/1/113We read with interest the commentary by Lima and
Bakker [1]. The authors note that there are two phases
in the shock state that differ in the degree of uncoupling
of macrocirculatory and microcirculatory function. They
suggest that a shift to flow-based resuscitation may offer
benefit for the critically ill by prioritising microcirculatory
perfusion. This commentary is of particular interest when
viewed in the context of ProCess [2], the recent negative
early goal-directed therapy study.
The absence of a treatment effect in this trial from the
therapies one would normally expect to resuscitate the
microcirculation warrants consideration. Resuscitation
attempts that reverse microcirculatory dysfunction early
in the shock state appear to offer clinical benefit [3]. Con-
versely, in the phase of established shock the primary
function of the microcirculation may be limiting damage
by preventing spread of infection [4] and harmful excess
oxygen delivery in parallel with mitochondrial shutdown
and reduced oxygen consumption [5]. Microcirculatory
dysfunction in established organ failure may therefore
in fact be adaptive. Re-recruitment as a result of zeal-
ous resuscitation could hence be predicted to result in
detrimental tissue effects. The ProCess trial utilised ag-
gressive resuscitation strategies, without an endpoint
that reflected microcirculatory perfusion in the context
of ongoing metabolic need. This could be predicted to
result in successful resuscitation of some patients and
harm to others, dependent on their individual phase of
illness.
We offer caution that despite the negative results from
the ProCess trial, the concept of early goal-directed ther-
apy should not yet be discounted, but should be revisited
once valid clinical measures of microcirculatory and meta-
bolic function are available.* Correspondence: john.moore@health.qld.gov.au
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